Study To Assess FRacTure Healing With SclerosTin Antibody - Hip

Clinical trial NCT01081678 · COMPLETED

Trial details

NCT number: NCT01081678
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Fracture Healing

Start date: 2010-06-20
Primary completion: 2012-06-30
Enrollment: 332

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.